Dabigatran in patients with nonvalvular atrial fibrillation

J Am Coll Cardiol. 2011 Jul 26;58(5):551; author reply 551. doi: 10.1016/j.jacc.2011.04.016.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Anticoagulants / pharmacokinetics
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / administration & dosage*
  • Benzimidazoles / adverse effects
  • Benzimidazoles / pharmacokinetics
  • Creatinine / blood
  • Creatinine / urine
  • Dabigatran
  • Dose-Response Relationship, Drug
  • Hemorrhage / chemically induced
  • Humans
  • Practice Guidelines as Topic
  • beta-Alanine / administration & dosage
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives*
  • beta-Alanine / pharmacokinetics

Substances

  • Anticoagulants
  • Benzimidazoles
  • beta-Alanine
  • Creatinine
  • Dabigatran